Blog
Ostarine vs LGD-4033: Research Comparison of MK-2866 and Ligandrol
Ostarine (MK-2866) and LGD-4033 (Ligandrol) are the two most extensively characterised selective androgen receptor modulators (SARMs) in the published scientific literature. Both were developed as investigational drugs targeting muscle wasting and bone density loss,…
SARMs Legal Status in Australia: TGA Scheduling, Research Use, and Regulatory Framework
Selective androgen receptor modulators (SARMs) occupy a distinct regulatory position in Australia — neither freely available consumer products nor entirely prohibited substances. Their legal status is determined by the Therapeutic Goods Administration (TGA) scheduling…
Ostarine Half-Life: What the Published Pharmacokinetic Data Actually Shows
One of the most frequently researched parameters for MK-2866 (Ostarine) is its elimination half-life — the time required for plasma concentration to decrease by 50% following administration. This parameter has direct relevance to dosing interval design in clinical…
MK-2866 Mechanism of Action: How Ostarine Works at the Receptor Level
MK-2866 — also designated GTX-024 and commonly known as Ostarine or Enobosarm — is a non-steroidal selective androgen receptor modulator (SARM) developed by GTx, Inc. Unlike classical androgens such as testosterone, MK-2866 was engineered to activate androgen…
Ostarine Purity Standards: What Researchers Should Expect
Compound purity is one of the most consequential variables in research involving synthetic pharmacological agents. When working with MK-2866 (Ostarine), a widely used SARM in receptor pharmacology and musculoskeletal research, the purity of the compound directly…
How to Verify a Research Compound COA: A Step-by-Step Guide
A Certificate of Analysis (COA) is the primary documentation that links a batch of research compound to independently verified analytical data. For researchers sourcing MK-2866 (Ostarine) or any other research chemical, the ability to read and critically evaluate a…